Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Urinary Tract Infections D014552 11 associated lipids
Urticaria D014581 13 associated lipids
Vertigo D014717 4 associated lipids
Vomiting D014839 21 associated lipids
Whooping Cough D014917 6 associated lipids
Wound Infection D014946 12 associated lipids
Yaws D015001 4 associated lipids
Superinfection D015163 3 associated lipids
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Dry Eye Syndromes D015352 10 associated lipids
Weight Gain D015430 101 associated lipids
Weight Loss D015431 56 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Frontal Sinusitis D015522 1 associated lipids
Corneal Edema D015715 3 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Uveitis, Intermediate D015867 3 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Pneumocystis Infections D016720 1 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Common Variable Immunodeficiency D017074 4 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Pelvic Pain D017699 7 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Furcation Defects D017823 1 associated lipids
T-Lymphocytopenia, Idiopathic CD4-Positive D018344 1 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Parasitemia D018512 5 associated lipids
Abdominal Abscess D018784 2 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Pseudolymphoma D019310 1 associated lipids
Pouchitis D019449 3 associated lipids
Syncope, Vasovagal D019462 1 associated lipids
Acquired Hyperostosis Syndrome D020083 1 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Focal Nodular Hyperplasia D020518 1 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Bremond-Gignac D et al. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients. 2010 Pediatr. Infect. Dis. J. pmid:19935122
Pichichero ME et al. Azithromycin for the treatment of pertussis. 2003 Pediatr. Infect. Dis. J. pmid:14515842
Toltzis P et al. Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media. 2007 Pediatr. Infect. Dis. J. pmid:17596812
Ferrarini A et al. Henoch-Schönlein syndrome and pertussis. 2007 Pediatr. Infect. Dis. J. pmid:17596820
Wubbel L et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. 1999 Pediatr. Infect. Dis. J. pmid:10048679
Snelling PJ et al. Rhabdomyolysis Complicating Typhoid Fever in A Child and Review of the Literature. 2017 Pediatr. Infect. Dis. J. pmid:28430751
Pacifico L and Chiesa C Efficacy of three-day azithromycin vs. ten-day penicillin V in the treatment of streptococcal pharyngitis. 1997 Pediatr. Infect. Dis. J. pmid:9154566
Banerjee R et al. Azithromycin treatment of recurrent respiratory tract infections in children. 2005 Pediatr. Infect. Dis. J. pmid:16282955
Heiman KE et al. Shigellosis with decreased susceptibility to azithromycin. 2014 Pediatr. Infect. Dis. J. pmid:25361413
Nightingale CH Pharmacokinetics and pharmacodynamics of newer macrolides. 1997 Pediatr. Infect. Dis. J. pmid:9109156
Block SL Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. 1997 Pediatr. Infect. Dis. J. pmid:9109158
Tarlow MJ et al. Future indications for macrolides. 1997 Pediatr. Infect. Dis. J. pmid:9109159
Shelby-James TM et al. Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children. 2002 Pediatr. Infect. Dis. J. pmid:12150171
Belvisi V et al. Bartonella henselae infection presenting with ocular and hepatosplenic manifestations in an immunocompetent child. 2012 Pediatr. Infect. Dis. J. pmid:22801097
Yee CL et al. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. 2002 Pediatr. Infect. Dis. J. pmid:12182376
Gordon EM and Blumer JL Rationale for single and high dose treatment regimens with azithromycin. 2004 Pediatr. Infect. Dis. J. pmid:14770072
Meyer Sauteur PM et al. Neuroinvasive Mycoplasma pneumoniae infection without intrathecal antibody response. 2012 Pediatr. Infect. Dis. J. pmid:22760530
Meloni G and Meloni T Azithromycin vs. doxycycline for Mediterranean spotted fever. 1996 Pediatr. Infect. Dis. J. pmid:8933556
Morita JY et al. Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. 2000 Pediatr. Infect. Dis. J. pmid:10643849
Arguedas A et al. Single dose azithromycin for the treatment of uncomplicated otitis media. 2004 Pediatr. Infect. Dis. J. pmid:14770073
Jackson MA et al. Breakthrough sepsis in macrolide-resistant pneumococcal infection. 1996 Pediatr. Infect. Dis. J. pmid:8933560
Arrieta A and Singh J Management of recurrent and persistent acute otitis media: new options with familiar antibiotics. 2004 Pediatr. Infect. Dis. J. pmid:14770074
Cohen R Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. 2004 Pediatr. Infect. Dis. J. pmid:14770076
Whitty CJ et al. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. 1999 Pediatr. Infect. Dis. J. pmid:10571428
Ruuskanen O Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update. 2004 Pediatr. Infect. Dis. J. pmid:14770077
Klein JO and Schaad UB [Use of azithromycin in the treatment of acute otitis media and tonsillopharyngitis: summary and conclusions. 2004 Pediatr. Infect. Dis. J. pmid:14770078
Raju M et al. Atovaquone and azithromycin treatment for babesiosis in an infant. 2007 Pediatr. Infect. Dis. J. pmid:17259886
Morrison W Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. 2007 Pediatr. Infect. Dis. J. pmid:17259889
Dagan R et al. Resistant organisms and otitis media. 2005 Pediatr. Infect. Dis. J. pmid:16148862
Watson ME and Storch GA Recurrent Mycoplasma pneumoniae infection in a human immunodeficiency virus-positive child. 2008 Pediatr. Infect. Dis. J. pmid:18985833
Gonzalez BE et al. Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. 2004 Pediatr. Infect. Dis. J. pmid:15131461
Cohen R et al. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. 2002 Pediatr. Infect. Dis. J. pmid:12075760
Schaad UB et al. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. 2002 Pediatr. Infect. Dis. J. pmid:12075761
Miron D et al. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis. 2004 Pediatr. Infect. Dis. J. pmid:15071299
Aderinboye O and Syed SS Congenital babesiosis in a four-week-old female infant. 2010 Pediatr. Infect. Dis. J. pmid:20118748
Boccazzi A et al. Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. 2000 Pediatr. Infect. Dis. J. pmid:11055597
Saegeman V et al. Management of macrolide-resistant Mycoplasma pneumoniae infection. 2012 Pediatr. Infect. Dis. J. pmid:22668803
Minodier P et al. Cutaneous leishmaniasis treated with azithromycin in a child. 2008 Pediatr. Infect. Dis. J. pmid:18162948
Arguedas A et al. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. 2005 Pediatr. Infect. Dis. J. pmid:15702045
Jacobs RF et al. Pharmacokinetics of intravenously administered azithromycin in pediatric patients. 2005 Pediatr. Infect. Dis. J. pmid:15665708
Powers JL et al. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. 2000 Pediatr. Infect. Dis. J. pmid:11144401
Tramper-Stranders GA et al. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function. 2007 Pediatr. Infect. Dis. J. pmid:17195698
Toltzis P et al. Comparative effects of single-dose ceftriaxone versus three oral antibiotic regimens on stool colonization by resistant bacilli in children. 2007 Pediatr. Infect. Dis. J. pmid:17195701
Esposito S et al. Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections. 2005 Pediatr. Infect. Dis. J. pmid:15876944
Gomperts BN and White LK Gonococcal hand abscess. 2000 Pediatr. Infect. Dis. J. pmid:10917235
Glanternik JR et al. A Cluster of Cases of Babesia microti Among Neonates Traced to a Single Unit of Donor Blood. 2018 Pediatr. Infect. Dis. J. pmid:28945680
Adegbola RA et al. Effect of azithromycin on pharyngeal microflora. 1995 Pediatr. Infect. Dis. J. pmid:7603826
Jain SK et al. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility. 2005 Pediatr. Infect. Dis. J. pmid:15933557
Hoberman A et al. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. 2005 Pediatr. Infect. Dis. J. pmid:15933563
Dagan R et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. 2000 Pediatr. Infect. Dis. J. pmid:10693993
Bowden FJ et al. Donovanosis causing cervical lymphadenopathy in a five-month-old boy. 2000 Pediatr. Infect. Dis. J. pmid:10694010
Fleming-Dutra KE et al. Variations in Antibiotic and Azithromycin Prescribing for Children by Geography and Specialty-United States, 2013. 2018 Pediatr. Infect. Dis. J. pmid:28746259
Dagan R et al. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. 1998 Pediatr. Infect. Dis. J. pmid:9802628
Bass JW et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. 1998 Pediatr. Infect. Dis. J. pmid:9655532
Klein JO History of macrolide use in pediatrics. 1997 Pediatr. Infect. Dis. J. pmid:9109154
Klein JO Clarithromycin and azithromycin. 1998 Pediatr. Infect. Dis. J. pmid:9655546
McCracken GH Microbiologic activity of the newer macrolide antibiotics. 1997 Pediatr. Infect. Dis. J. pmid:9109155
Tarlow MJ Macrolides in the management of streptococcal pharyngitis/tonsillitis. 1997 Pediatr. Infect. Dis. J. pmid:9109157
Dagan R et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. 1998 Pediatr. Infect. Dis. J. pmid:9779760
Girgis N et al. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. 1998 Pediatr. Infect. Dis. J. pmid:9779768
Reed MD and Blumer JL Azithromycin: a critical review of the first azilide antibiotic and its role in pediatric practice. 1997 Pediatr. Infect. Dis. J. pmid:9384342
Hammerschlag MR et al. Treatment of neonatal chlamydial conjunctivitis with azithromycin. 1998 Pediatr. Infect. Dis. J. pmid:9849993
Arnež M and Ružić-Sabljić E Azithromycin Is Equally Effective as Amoxicillin in Children with Solitary Erythema Migrans. 2015 Pediatr. Infect. Dis. J. pmid:26186104
Basualdo W and Arbo A Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. 2003 Pediatr. Infect. Dis. J. pmid:12712971
Soni N et al. Recurrent acute interstitial nephritis induced by azithromycin. 2004 Pediatr. Infect. Dis. J. pmid:15602202
Schaad UB and Heynen G Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group. 1996 Pediatr. Infect. Dis. J. pmid:8878223
Aronovitz G A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children. 1996 Pediatr. Infect. Dis. J. pmid:8878241
McLinn S A multicenter, double blind comparison of azithromycin and amoxicillin/ clavulanate for the treatment of acute otitis media in children. 1996 Pediatr. Infect. Dis. J. pmid:8878242
Khurana CM A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school. 1996 Pediatr. Infect. Dis. J. pmid:8878243
Powers JL Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. 1996 Pediatr. Infect. Dis. J. pmid:8878244
Toltzis P et al. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. 2006 Pediatr. Infect. Dis. J. pmid:16395097
Farooq O et al. Azithromycin-induced agitation and choreoathetosis. 2011 Pediatr. Neurol. pmid:21397177
Weinberger M et al. Diffuse panbronchiolitis in a 10-year-old boy. 2015 Pediatr. Pulmonol. pmid:25824890
Schultz KD and Oermann CM Treatment of cast bronchitis with low-dose oral azithromycin. 2003 Pediatr. Pulmonol. pmid:12526076
Nguyen D et al. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes. 2007 Pediatr. Pulmonol. pmid:17469154
Kogan R et al. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. 2003 Pediatr. Pulmonol. pmid:12526069
Jubin V et al. Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. 2010 Pediatr. Pulmonol. pmid:20597074
Ratjen F et al. Response to letter. 2015 Pediatr. Pulmonol. pmid:24700677
Kneyber MC et al. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. 2008 Pediatr. Pulmonol. pmid:18085694
Zemanick ET et al. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures. 2010 Pediatr. Pulmonol. pmid:20503282
Saiman L et al. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. 2012 Pediatr. Pulmonol. pmid:22684984
Wilms EB et al. Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects. 2012 Pediatr. Pulmonol. pmid:22684985
Willekens J et al. How long should we maintain long-term azithromycin treatment in cystic fibrosis patients? 2015 Pediatr. Pulmonol. pmid:24464958
Luo Z et al. Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children. 2014 Pediatr. Pulmonol. pmid:23401275
Arıkan-Ayyıldız Z et al. Survival of an infant with homozygous surfactant protein C (SFTPC) mutation. 2014 Pediatr. Pulmonol. pmid:24347240
ElMallah MK et al. Plastic bronchitis: resolution after heart transplantation. 2011 Pediatr. Pulmonol. pmid:21465672
Ballard HO et al. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial. 2011 Pediatr. Pulmonol. pmid:20963840
Aghai ZH et al. Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. 2007 Pediatr. Res. pmid:17667842
Walls SA et al. Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice. 2009 Pediatr. Res. pmid:19390479
Londhe VA et al. Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung. 2011 Pediatr. Res. pmid:21270677
Weisman LE et al. Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse. 2012 Pediatr. Res. pmid:22907617
Eberly MD et al. Azithromycin in early infancy and pyloric stenosis. 2015 Pediatrics pmid:25687145
Oluwalana C et al. Azithromycin in Labor Lowers Clinical Infections in Mothers and Newborns: A Double-Blind Trial. 2017 Pediatrics pmid:28130432
Cogen JD et al. Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations. 2017 Pediatrics pmid:28126911
Langley JM et al. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. 2004 Pediatrics pmid:15231980
Smith MJ et al. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children. 2012 Pediatrics pmid:22492769
Cohen DA et al. A school-based Chlamydia control program using DNA amplification technology. 1998 Pediatrics pmid:9417165
Amer A and Fischer H Azithromycin does not cure pityriasis rosea. 2006 Pediatrics pmid:16651327
Clavier A and Hupert J Azithromycin for pityriasis. 2006 Pediatrics pmid:17079605
Fox JW et al. Recurrent expressive aphasia as a presentation of cat-scratch encephalopathy. 2007 Pediatrics pmid:17332191